SCHEMBL20758809

SCHEMBL20758809

O=C(O)COc1cc(OCC(=O)O)cc(C(=O)OCc2ccccc2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.60
TDP1 Q9NUW8 2/20 0.60
SLC6A2 P23975 1/20 0.60
SLC6A3 Q01959 1/20 0.60
MEN1 O00255 1/20 0.58
LMNA P02545 4/20 0.55
ALOX15 P16050 1/20 0.51
LTB4R Q15722 1/20 0.50
LTB4R2 Q9NPC1 1/20 0.50
ALDH1A1 P00352 4/20 0.49
RAB9A P51151 4/20 0.49
NPC1 O15118 3/20 0.49
MAPT P10636 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
HPGD P15428 1/20 0.49
KDM4E B2RXH2 1/20 0.48
PPARG P37231 1/20 0.48
PPARD Q03181 1/20 0.48
NR4A2 P43354 1/20 0.48
PTPN7 P35236 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18736529 0.94 KMT2A (0.54) KMT2ATDP1SLC6A2SLC6A3MEN1
SCHEMBL18736332 0.92 TDP1 (0.54) KMT2ATDP1SLC6A2SLC6A3MEN1
SCHEMBL22257619 0.90 KMT2A (0.53) KMT2ATDP1SLC6A2SLC6A3MEN1
SCHEMBL22498801 0.90 PPARG (0.56) KMT2ATDP1SLC6A2SLC6A3MEN1
SCHEMBL16897964 0.89 KMT2A (0.73) KMT2ATDP1SLC6A2SLC6A3MEN1
SCHEMBL18703863 0.88 KMT2A (0.61) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL18705337 0.88 PPARD (0.56) KMT2ATDP1SLC6A2SLC6A3MEN1
SCHEMBL18736318 0.87 NPC1 (0.52) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL20758458 0.86 KMT2A (0.51) KMT2ATDP1SLC6A2SLC6A3MEN1
SCHEMBL4500586 0.86 KMT2A (0.67) KMT2ATDP1SLC6A2SLC6A3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127605-A1 NUCLEIC ACID CONJUGATE KYOWA KIRIN CO., LTD. (JP) 2022-04-28 US disclosed
US-10745700-B2 Nucleic acid conjugate KYOWA KIRIN CO., LTD. (JP) 2020-08-18 US disclosed
US-20190192674-A1 NUCLEIC ACID CONJUGATE KYOWA HAKKO KIRIN CO., LTD. (JP) 2019-06-27 US disclosed
US-20190055558-A1 NUCLEIC ACID CONJUGATE KYOWA HAKKO KIRIN CO., LTD. (JP) 2019-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127605-A1 NUCLEIC ACID CONJUGATE NSUN3, NSUN2, RNASEH1 KMT2A 1750/4885TDP1 613/4885SLC6A2 1074/4885
US-10745700-B2 Nucleic acid conjugate SLC29A1, NSUN2, H1-2 KMT2A 871/4885TDP1 410/4885SLC6A2 883/4885
US-20190192674-A1 NUCLEIC ACID CONJUGATE M6PR, NSUN2, NSUN3 KMT2A 577/4885TDP1 2231/4885SLC6A2 918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.